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Abstract
Introduction: Extracorporeal membrane oxygenation (ECMO) is increasingly used in cardiac arrest (CA). Adequacy
of carotid and coronary blood flows (CaBF, CoBF) and coronary perfusion pressure (CoPP) in ECMO treated CA is
not well established. This study compares femoro-femoral (FF) to femoro-subclavian (FS) ECMO and intraaortic
balloon counterpulsation (IABP) contribution based on CaBF, CoBF, CoPP, myocardial and brain oxygenation in
experimental CA managed by ECMO.
Methods: In 11 female pigs (50.3 ± 3.4 kg), CA was randomly treated by FF versus FS ECMO ± IABP. Animals under
general anesthesia had undergone 15 minutes of ventricular fibrillation (VF) with ECMO flow of 5 to 10 mL/kg/min
simulating low-flow CA followed by continued VF with ECMO flow of 100 mL/kg/min. CaBF and CoBF were
measured by a Doppler flow wire, cerebral and peripheral oxygenation by near infrared spectroscopy. CoPP,
myocardial oxygen metabolism and resuscitability were determined.
Results: CaBF reached values > 80% of baseline in all regimens. CoBF > 80% was reached only by the FF ECMO,
90.0% (66.1, 98.6). Addition of IABP to FF ECMO decreased CoBF to 60.7% (55.1, 86.2) of baseline, P = 0.004. FS
ECMO produced 70.0% (49.1, 113.2) of baseline CoBF, significantly lower than FF, P = 0.039. Addition of IABP to FS
did not change the CoBF; however, it provided significantly higher flow, 76.7% (71.9, 111.2) of baseline, compared
to FF + IABP, P = 0.026. Both brain and peripheral regional oxygen saturations decreased after induction of CA to
23% (15.0, 32.3) and 34% (23.5, 34.0), respectively, and normalized after ECMO institution. For brain saturations, all
regimens reached values exceeding 80% of baseline, none of the comparisons between respective treatment
approaches differed significantly. After a decline to 15 mmHg (9.5, 20.8) during CA, CoPP gradually rose with time
to 68 mmHg (43.3, 84.0), P = 0 .003, with best recovery on FF ECMO. Resuscitability of the animals was high, both
5 and 60 minutes return of spontaneous circulation occured in eight animals (73%).
Conclusions: In a pig model of CA, both FF and FS ECMO assure adequate brain perfusion and oxygenation. FF
ECMO offers better CoBF than FS ECMO. Addition of IABP to FF ECMO worsens CoBF. FF ECMO, more than FS
ECMO, increases CoPP over time.
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Introduction
A venoarterial (VA) extracorporeal membrane oxygena-
tion (ECMO) based approach is used for urgent hemody-
namic stabilization in patients with profound cardiogenic
shock and, increasingly, also in cardiac arrest, both dur-
ing in-hospital and out-of-hospital cardiac arrest in
adults [1-7], in prolonged refractory cardiac arrest [7,8],
for in-hospital pediatric cardiac arrest [9,10] and,
recently, has even been discussed for out-of hospital “on
scene” refractory cardiac arrest management [11]. This
approach, also referred to as extracorporeal cardiopul-
monary resuscitation (E-CPR) allows perfusion of vital
organs during cardiac arrest and provides a time span for
diagnosis and therapy [12]. The most demanding vital
organs are the brain and the heart, and their adequate
oxygenation and perfusion are critical prerequisites for
favorable clinical outcomes [13,14]. Additionally, most
cardiac arrests, including refractory cases, are caused by
either acute coronary or other cardiac events, which may
have treatable causes [12]. In clinical practice, a combina-
tion of a pulsatile support by intraaortic balloon counter-
pulsation (IABP) with ECMO is considered beneficial
and is used both in ECMO-treated cardiogenic shock and
during weaning from extracorporeal support [15]. How-
ever, it remains unclear whether coronary and carotid
blood flows and coronary perfusion pressure in pro-
longed cardiac arrest are adequate when managed by
different ECMO approaches [16-18].
The aim of our experimental study was to determine
how femoro-femoral (FF) compares to femoro-subclavian
(FS) VA ECMO in producing adequate carotid and cor-
onary blood flow as well as cerebral and myocardial oxy-
genation in a pig model of prolonged cardiac arrest, and
whether the contribution of IABP in these ECMO
approaches is significant. We further investigated
whether both FF and FS ECMO assure adequate coron-
ary perfusion pressure (CoPP) and offer a reasonable
resuscitability despite a prolonged period of ventricular
fibrillation (VF).
We hypothesized that FF ECMO might better assure
carotid blood flow than FS ECMO and FS ECMO being
more proximal will better supply coronary arteries. We
also anticipated that IABP will improve both carotid and
coronary blood flows. We further hypothesized that VA
ECMO will provide sufficient myocardial oxygen sup-
port and CoPP reflected in a reasonable resuscitability.
Materials and methods
This study was approved by the First Faculty of Medi-
cine Institutional Animal Care and Use Committee and
performed at the Animal Laboratory, Department of
Physiology, First Faculty of Medicine, Charles University
in Prague in accordance with Act No 246/1992 Coll., on
the protection of animals against cruelty.
Twelve crossbred (Landrace × large white) female pigs
(Sus scrofa domestica), four to five months old, mean
body weight 50.3 ± 3.4 kg, were used in the study. After
24 h of fasting, anesthesia was induced by azaperone
(2 mg/kg IM) followed by atropine sulphate (0.02 mg/kg
IM) and ketamine hydrochloride (15 to 20 mg/kg IM).
Anesthesia was continued with initial propofol and mor-
phine boluses, (2 mg/kg IV and 0.1 to 0.2 mg/kg IV,
respectively) and animals were orotracheally intubated.
Continuous IV infusion of propofol (8 to 10 mg/kg/h)
combined with morphine (0.1 to 0.2 mg/kg/h) IV were
used to maintain anesthesia, the depth of which was reg-
ularly assessed by photoreaction and corneal reflex.
Initial rapid IV infusion of 1,000 mL of normal saline was
given intravenously, followed by continuous IV drip of
200 to 500 mL/h to reach and maintain central venous
pressure of 3 to 7 mmHg. Whenever needed, mainly dur-
ing initial launching of ECMO, additional crystalloids
were administered as rapid IV boluses of 100 to 250 ml
of normal saline. Unfractionated heparin (100 U/kg IV)
was given as a bolus after sheaths placement followed by
40 to 50 U/kg/h continuous IV drip to maintain activated
clotting time of 180 to 250 s (values were checked every
hour with Hemochron Junior+, International Technidyne
Corporation, Edison, NJ, USA).
For methods on ventilation, hemodynamic monitoring,
high-frequency burst method to induce VF, laboratory
values determination, cardiac O2 extraction determina-
tion, IABP institution and ECMO console, and circuit
and cannulation, please refer to Additional file 1.
Brain and peripheral regional oxygen saturation levels
were measured by near infrared spectroscopy (NIRS)
using an INVOS Cerebral/Somatic Oximeter (Covidien,
Boulder, CO, USA). Two spectroscopy sensors were
used, one overlying the forehead and the other attached
to the calf, opposite to the side where an arterial
femoral ECMO cannula was inserted.
Coronary and carotid direct blood flow velocity mea-
surement (see Additional file 2) was performed with a
Doppler flow wire using ComboMap Pressure and Flow
Measurement System (Volcano Corporation, Rancho
Cordova, CA, USA). Doppler flow wires were inserted
into straight proximal segments of coronary and carotid
arteries through the guiding catheters for percutaneous
coronary or carotid interventions, 2 to 3 cm behind the
catheter orifices. A blood flow Doppler signal was
obtained and analyzed in real-time, blood flow velocity
was measured in cm/sec as an average peak value (APV)
obtained from five consecutive instantaneous peak velo-
city (IPV) measurements. A mean APV during last min-
ute of respective five-minute sampling periods were
used for averaging. Values were stored for further off-
line analysis and APV considered as a surrogate marker
of coronary artery blood flow [19,20].
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Experimental protocol
Under fluoroscopic guidance, a coronary 6 F AR1 guiding
catheter (Cordis, Miami, Fl, USA) was placed into the
ostium of the left main coronary artery and a 6 F Head-
hunter carotid access or RCB guiding catheter (Cordis)
was placed directly into the left carotid artery, or through
the bicarotid trunk whenever present, 1 to 2 cm behind
the ostium. An IABP balloon was inserted into the des-
cending aorta and Swan-Ganz and coronary sinus cathe-
ters were advanced under fluoroscopic control.
The right subclavian artery was surgically exposed and a
15 F ECMO cannula was inserted with its tip positioned
to the origin of the right subclavian artery for later extra-
corporeal circuit connection. The cannula was clamped
and continuously flushed with heparinized saline to avoid
thrombosis. Thereafter, Doppler flow wires were inserted
through guiding catheters to be positioned approximatelly
3 to 5 cm above the origin of the left carotid artery and in
the proximal straight segment of the circumflex coronary
artery, see Additional file 2. The Doppler wires were care-
fully manipulated and placed for obtaining the best possi-
ble ultrasound signals. The protocol consisted of 15-
minute intervention intervals outlined in Figure 1. Follow-
ing stabilization, all hemodynamic and flow values in each
of these intervals were obtained every five minutes and
averaged, the blood was always drawn at the end of each
interval. The baseline interval was followed by the IABP
set to a 1:1 mode to adjust for the best possible augmenta-
tion. Thereafter, the ECMO cannulae were inserted
according to randomization: in the FF arm, both venous
and arterial femoral cannulae; in the case of the FS arm,
only a venous femoral cannula was inserted and the pre-
viously prepared subclavian cannula was used. Fluorosco-
pically, femoral artery ECMO cannula position was
controlled not to be in close proximity to the IABP
balloon to avoid interference with aortic ECMO flow.
Initially, a basal mode of < 10 mL/kg/minute blood flow
was set for stabilization. Next, a maximal ECMO flow
mode was defined by a blood flow rate of 100 to 130 mL/
kg/minute. Then, cardiac arrest was commenced by VF
induction using programmed ventricular stimulation and
ECMO flow was set to 5 to 10 mL/kg/minute. After
15 minutes of cardiac arrest, the ECMO flow was
increased to reach the target flow of 100 mL/kg/minute as
soon as possible. After finishing the ECMO interval and
all data retrieval, IABP was switched on to an internal
mode of 100 inflations/minute. Then, an ECMO switch
procedure was carried out and all values were again
retrieved from ECMO and ECMO + IABP configurations.
Vasopressors were not used in these ECMO-treated
phases of cardiac arrest. After all values and blood speci-
mens were obtained, standard CPR including chest com-
pressions, whenever needed, were started with 270 J
biphasic DC defibrillation (TEC-550, Nihon Kohden,
Japan). Return of spontaneous circulation (ROSC) was
evaluated based on the following definition: a supraventri-
cular rhythm with hemodynamically effective pulsations
regardless of ECMO flow with mean arterial pressure of
60 mmHg. The evaluation took place at 5 and 60 minutes
following first defibrillation. An ECMO weaning trial was
Figure 1 Outline of the study protocol. For an explanation see text. Vertical bars represent 15-minute intervals for respective measurement
periods. CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; FF, femoro-femoral; FS, femoro-subclavian; IABP,
intraaortic balloon countepulsation; VF, ventricular fibrillation; ROSC, return of spontaneous circulation.
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performed regularly and until 60 minutes post CPR,
hemodynamic tolerance was tested. Hypotension was even-
tually corrected with standard norepinephrine dosing
administered continuously by an IV drip. Thereafter, the
animal was euthanized by morphine and propofol overdose
followed by intravenous potasium chloride 1 mmol/kg.
Statistical analysis
Descriptive data are presented as median (interquartile
range) of measured values or as median (interquartile
range) of individual baseline percentages of each experi-
ment. The median of baseline percentage is not percent
expression of absolute value median. It is a median of
baseline percentage from each experiment. Repeated ana-
lysis of variance measures were used to assess the
between-subject effect within each arm of the study (that
is, we assessed the effect of the ordering of ECMO proce-
dures as one arm started with FF ECMO, whereas the
other started with FS ECMO; Figure 1). No difference
was noticed. We then pooled the corresponding methods
from both arms to assess the differences. Each animal
was used as its own control, and paired comparisons
were made between respective approaches. A Friedman
test and Tukey’s post hoc analysis were performed for dif-
ferent analyses of ECMO approaches. P-values < 0.05
were considered statistically significant. All statistical
analyses were performed by MedCalc software version
11.6. (MedCalc Software, Broekstraat 52, 9030 Maria-
kerke, Belgium) and MATLAB Statistics Toolbox (Math-
Works Inc., Natick, MA, USA).
Results
Out of 12 animals entered in the study, 11 animals suc-
cessfully completed the full protocol and all data were
retrieved and used for evaluation. The single animal that
did not complete the study developed massive retroperi-
toneal bleeding during venous ECMO cannula insertion
and died of refractory hemorrhagic shock. The initial pre-
paration period encompassing all cannulations and surgi-
cal implantation of the subclavian ECMO cannula,
ECMO tolerance and effectivity testing lasted 5:01 hours
(4:28, 5:33), cardiac arrest 15:33 min (13:59,16:08) and
ECMO switch procedure 2:12 minutes (0:29, 3:15). Over-
all protocol duration was 7:18 hours (6:30, 7:55). Average
fluid (saline) loading during the whole experiment was
4.622 ± 1.103 ml to reach target central venous pressure
values and to avoid ECMO underfilling. In all animals,
target ECMO flow of 100 mL/kg/minute has been
reached, in three animals (#1, 6, 11) pulmonary edema
developed.
Carotid and coronary blood flow velocities
Carotid and coronary blood flow velocities presented as
average peak velocities are enumerated in Table 1.
Absolute values give velocities at baseline, cardiac arrest
and different ECMO regimens. Cardiac arrest values of
12 (7.0, 12.0) cm/sec for carotid and 8 (7.0, 9.8) cm/sec
for coronary flow velocities reflect very low flows gener-
ated by basal ECMO setting to prevent thrombosis
within the ECMO circuit and simulating a “low-flow”
cardiac arrest state. Relative carotid and coronary blood
flow velocities according to different ECMO regimens
during the continued cardiac arrest treated by ECMO
are graphically outlined with respective statistical evalua-
tion in Figure 2.
Carotid flow velocities in all ECMO approaches
regardless of IABP presence reached values higher than
80% of baseline flow and were near to 100% of baseline
values in both FS and FS + IABP configurations. Addi-
tion of IABP to FF ECMO did not change the carotid
flow significantly.
Coronary flow velocities are lower, reaching about a
half of the carotid velocities. Only the FF regimen assures
values over 80% of baseline. Addition of IABP to the FF
approach caused a statistically significant decrease in cor-
onary flow velocity, P = 0.004. The FS ECMO approach
reached only 70.0% (49.1, 113.2) of the baseline flow,
which is significantly lower than 90.0% (66.1, 98.6) of FF
ECMO, P = 0.039. Addition of IABP to FS did not signifi-
cantly change the coronary blood flow velocity. Compari-
son of both IABP regimens shows a statistically
significant difference, FS +IABP vs. FF + IABP 76.7%
(71.9, 111.2) vs. 60.7% (55.1, 86.2), P = 0.026. Thus, the
FF+IABP approach reached the lowest coronary flow
velocities in this cardiac arrest setting.
Brain and peripheral oxygen saturations
Brain and peripheral regional oxygen saturations are
demonstrated in Table 2, and the values relative to base-
line during different ECMO regimens and statistical eva-
luation are outlined in Additional file 3. Both brain and
peripheral regional oxygen saturations dramatically
decreased immediately after induction of VF cardiac
arrest to 23.0% (15.0, 32.3), P = 0.001, and 34.0% (23.5,
34.0), P = 0.001, in absolute values versus baseline,
respectively, and after restoration of flow rapidly
improved. Thus, for brain saturations both ECMO regi-
mens reached values exceeding 80% of baseline and simi-
lar ranges apply for IABP assistance. Comparably similar
values were detected also for peripheral saturations.
None of the comparisons for brain or peripheral satura-
tions differed significantly.
Coronary perfusion pressure progress during the
experiment
Immediatelly after induction of VF and cardiac arrest, the
CoPP decreased from a baseline of 84 mmHg (69.7, 97.0)
to 15 mmHg (9.5, 20.8). Of note, animals randomized to
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FS starting cohort, tended to have nonsignificantly lower
pre-arrest CoPP. The first CoPP value on ECMO was 34
mmHg (25.8, 45.5) and later during the protocol gradu-
ally rose. This phenomenon of a gradual rise with time
was detected in almost all animals except for two of
them, see Figure 3 and Additional file 4 and was present
both in the FS and FF arms of the protocol. A more pro-
nounced increase in CoPP values was detected in the FF
ECMO arm (see Figure 4). Table 3 demonstrates the
actual progress of CoPP, MAP and CVP values during
the experiment and their respective differences according
to a randomization assignment. Baseline pulmonary
capillary wedge pressure and cardiac output values are
also shown to demonstrate comparable baseline values in
respect to treatment arms. Statistical evaluations compar-
ing baseline CoPP values with values reached before CPR
and ECMO onset values with those before CPR values
are outlined in Figures 3 and 4. The final CoPP value at
the end of the protocol, that is, after ECMO-treated
cardiac arrest of more than two hours on average,
reached almost the baseline value. Animals started on FF
ECMO completed the protocol with identical CoPP values
as at the baseline, with a steep rise in CoPP during the FF
ECMO part of the protocol. The difference of initial CoPP
ECMO values between the FF versus FS treatment arms
was 10 mmHg (41 minus 31), P = 0.193, increased to a sig-
nificant difference of 42.0 mmHg (77.0 minus 35.0) at the
time of ECMO switch, P = 0.045, and remained signifi-
cantly different before CPR, that is, 40.5 mmHg (86.0
minus 45.5 mmHg), P = 0.008. Animals starting on FS
ECMO had a similar rise in CoPP during the later phase
of the protocol, after a switch to FF ECMO. For more sta-
tistical differences, please see Figure 4.
Lactate levels and myocardial oxygen extraction
Lactate levels measured in the coronary artery ostium
and in the coronary sinus are outlined in the upper part
of Figure 5. Interestingly, we have detected significantly
higher levels of lactate in animals started on FS ECMO
following cardiac arrest in all post arrest periods (P =
0.016 and P = 0.035 for differences in arterial and cor-
onary sinus lactate levels, respectively). Moreover, after
a steep increase of lactate levels during cardiac arrest
and the first ECMO period, a plateau level and then a
slight decrease could be detected, which was more pro-
minent for the FF ECMO approach. The lower part of
Figure 5 demonstrates O2 extractions outlined similarly
as lactate levels. After a steep increase in O2 extraction
during cardiac arrest a very deep decline of O2 extrac-
tion related to ECMO initiation is apparent and these
low extractions remain further with no statistically sig-
nificant differences between the respective ECMO arms
(P for difference = 0.547).
Resuscitability
Resuscitability of the animals was high. Out of 11 ani-
mals, we gained 5 minutes ROSC in 8 animals (73%). 60
minutes ROSC was achieved in 8 (73%) animals (Addi-
tional file 5); however, see animal #3, in whom initial
hypotension (5 minutes ROSC assessment with mean
Table 1 Carotid and coronary blood flow average peak velocities during different ECMO regimens.
N = 11 Baseline Cardiac arrest FS FS+IABP FF FF+IABP
Flow Velocity (cm/s)
Carotid 36.7 (33.3, 46.8) 12.0 (7.0, 12.0) 32.0 (25.5, 43.5) 32.3 (27.3, 39.0) 35.0 (25.7, 48.0) 27.3 (24.7, 37.3)
Coronary 21.7 (19.3, 24.4) 8.0 (7.0, 9.8) 14.0 (10.3, 25.0) 17.0 (15.9, 23.0) 18.7 (16.4, 21.8) 15.7 (11.5, 18.8)
Flow Velocity
(% of baseline)
Carotid — 23.8 (20.5, 34.6) 101.5 (65.6, 108.6) 98.0 (76.4, 120.9) 90.3 (79.4, 129.1) 81.8 (64.7, 124.3)
Coronary — 32.6 (29.6, 42.3) 70.0 (49.1, 113.2) 76.7 (71.9, 111.2) 90.0 (66.1, 98.6) 60.7 (55.1, 86.2)
Assessment performed by Doppler flow wire measurements in cm/s (upper part) and as a percentage of baseline (bottom part). FS, femoro-subclavian; FF,
femoro-femoral; IABP, intraaortic balloon counterpulsation; The median of baseline percentage is not percent expression of absolute value median. It is a median
of baseline percentage from each experiment.
Figure 2 Carotid and coronary blood flow velocities relative to
baseline. Values are expressed as median percentages of baseline
with 25- and 75-percentiles represented by the vertical bars (for
actual values see Table 1) along with P-values for respective
comparisons at the bottom. Statistically significant differences in
bold. Cardiac arrest values are significantly different to all other
values, comparisons not shown.
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arterial pressure of 58 mmHg) improved markedly to
fullfil criteria for 60-minute ROSC. However, the ECMO
support of > 50 mL/kg/min was prolonged to keep per-
fusion pressure in 5 of 11 animals (#3, 4, 6, 8, 11). In
the rest of them, ECMO was weaned quickly after initial
CPR. Two animals could not be resuscitated to reach
ROSC, one developed pulseless electrical activity after
the first defibrillation (animal #1), the other suffered
refractory VF despite six defibrillations (animal #2).
Interestingly, these animals with unsuccessful CPR had
steep decreases in coronary perfusion pressure during
the ECMO phases, as described above, see Additional
file 4.
Discussion
Using a pig model replicating a VA ECMO treated car-
diac arrest due to prolonged VF, we confirmed that this
approach used in some specialized centers for urgent
organ support (via percutanous FF insertion) sufficiently
assures both cerebral and myocardial perfusion, oxygena-
tion, and rapidly improves the post arrest metabolic state.
In contrast to our hypothesis, a FS approach (despite suf-
ficiently maintaining brain perfusion and oxygenation)
was not an optimal option for maintaining coronary per-
fusion. Moreover, this latter approach offered worse
myocardial metabolic recovery. We also tested an often
encountered clinical combination of IABP with VA
ECMO. We found that when used along with the FF
ECMO approach, IABP significantly impaired coronary
perfusion in comparison to FF ECMO alone. Further-
more, we have shown that in the FS ECMO approach,
coronary flow after addition of IABP remained low, not
reaching even 80% of the baseline level.
This is an important finding, because the cause of
arrest is of cardiac origin in a majority of cases [3,12]. It
is well described that besides the primary cardiac
Table 2 Measured peripheral and brain regional oxygen saturations in % during different ECMO regimens.
N = 11 Baseline Cardiac arrest FS FS+IABP FF FF + IABP
Oxygen saturation (%)
Peripheral 56.7 (49.2, 62.7) 34.0 (23.5, 34.0) 49.7 (48.4, 55.5) 48.7 (44.7, 52.5) 54.0 (40.2, 57.6) 46.7 (41.1, 56.2)
Brain 56.0 (50.5, 58.1) 23.0 (15.0, 32.3) 49.0 (42.8, 52.4) 52.0 (47.2, 53.2) 50.7 (41.9, 58.0) 49.0 (42.4, 55.6)
Oxygen saturation
(% of baseline)
Peripheral — 53.7 (42.0, 63.5) 91.4 (79.4, 99.9) 86.9 (75.4, 96.1) 92.1 (76.4, 103.5) 94.5 (73.3, 98.2)
Brain — 39.2 (30.3, 55.9) 86.4 (83.4, 91.7) 90.1 (83.6, 99.8) 93.8 (80.8, 102.1) 91.9 (82.2, 97.6)
Absolute values outlined in upper part and percentage of baseline values in bottom part. FS, femoro-subclavian; FF, femoro-femoral; IABP, intraaortic balloon
counterpulsation; The median of baseline percentage is not percent expression of absolute value median. It is a median of baseline percentage from each
experiment.
Figure 3 Coronary perfusion pressure during the whole protocol. Pooled from all eleven animals as medians with 25- and 75-percentiles
represented by vertical bars. See the gradual rise of perfusion pressure after the ECMO start. Respective statistical comparisons delineated by
horizontal bars, statistically significant differences in bold:*****P = 0.076;****P = 0.007; *** P < 0.001; **P = 0.003; *P = 0.037.
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Figure 4 Coronary perfusion pressure progression over time and differences in respective ECMO approaches according to
randomization. Values in bold mean statistically significant difference. The pressure differences between the respective arms on “ECMO start”,
“ECMO switch” and “before CPR” are 10, 42 and 40.5 mmHg, respectively, see Table 3 for absolute values (P = 0.193 for “ECMO start”, P = 0.045
for “ECMO switch” and P = 0.008 for “before CPR” values). Statistical evaluation for CoPP progression within the respective arms is delineated by
horizontal bars with statistical evaluation as follows. P-values for FF arm: #####P = 0.7;####P = 0.39; ### P = 0.002; ##P = 0.006; #P = 0.02. P-values
for FS arm: *****P = 0.041, ****P = 0.004, ***P < 0.001, **P = 0.11, *P = 0.49.
Table 3 Coronary perfusion pressure, mean arterial pressure and central venous pressure progress during the
experiment.
CoPP (mmHg) Baseline Cardiac arrest ECMO start ECMO switch before CPR
Both Arms Together (N = 11) 84.0 (69.7, 97.0) 15.0 (9.5, 20.8) 34.0 (25.8, 45.5) 53.0 (34.0, 76.0) 68.0 (43.3, 84.0)
FS starting (N = 6) 78.5 (68.5, 89.3) 10.0 (7.5, 12.5) 31.0 (20.0, 35.0) 35.0 (28.0, 44.0) 45.5 (29.0, 68.0)
FF starting (N = 5) 85.0 (80.0, 99.0) 20.0 (18.0, 21.0) 41.0 (31.0, 47.8) 77.0 (72.3, 84.0) 86.0 (71.8, 88.3)
MAP (mmHg)
Both Arms Together (N = 11) 88.0 (75.8, 102.0) 24.0 (19.3, 32.5) 41.0 (35.3, 51.0) 61.0 (40.5, 83.5) 75.0 (50.0, 88.3)
FS starting (N = 6) 81.2 (72.0, 96.0) 20.5 (17.0, 23.0) 40.0 (34.0, 51.0) 41.0 (35.0, 51.0) 52.0 (36.0, 75.0)
FF starting (N = 5) 89.7 (83.6, 104.5) 31.0 (28.5, 35.8) 49.0 (38.5, 52.5) 85.0 (78.5, 88.0) 90.0 (77.3, 95.3)
CVP (mmHg)
Both Arms Together (N = 11) 5.2 (4.4, 6.0) 11.5 (10.0, 12.0) 7.0 (5.3, 8.0) 7.0 (6.3, 7.8) 7.0 (6.3, 7.0)
FS starting (N = 6) 5.3 (4.0, 6.0) 10.0 (9.8, 12.0) 6.5 (5.0, 9.0) 7.0 (7.0, 8.0) 7.0 (7.0, 8.0)
FF starting (N = 5) 4.7 (4.5, 6.4) 12.0 (10.5, 12.0) 7.0 (5.5, 8.0) 7.0 (5.3, 7.3) 7.0 (4.8, 7.0)
PCWP (mmHg)
Both Arms Together (N = 11) 9.0 (8.0, 10.5)
FS starting (N = 6) 9.0 (8.0, 10.0)
FF starting (N = 5) 9.0 (7.5, 11.3)
CO (L/min)
Both Arms Together (N = 11) 6.4 (5.4, 7.5)
FS starting (N = 6) 6.2 (5.4, 7.5)
FF starting (N = 5) 6.8 (5.5, 7.5)
Baseline pulmonary capillary wedge pressure and cardiac output values are also shown in the lower part. None of the baseline differences between treatment
arms are statistically significant.
FS, femoro-subclavian; FF, femoro-femoral; CO, cardiac output; CoPP, coronary perfusion pressure; CPR, cardiopulmonary resuscitation; CVP, central venous
pressure; MAP, mean arterial pressure
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disease, nonpulsatile ECMO flow may adversely affect
cardiac performance in critical states, including hypoxe-
mic blood perfusion of the coronary circulation due to a
pulmonary dysfunction [21], changes in load-dependent
contractile function [22] and pure mechanical negative
effect on LV function [23]. A controversial effect on
afterload changes has also been described [24,25]. It
appears that cannulation selection, that is, subclavian/
carotid arterial ECMO cannula position and the magni-
tude of bypass flow also play a critical role in coronary
blood flow, depending on the distance from the coronary
arteries, and thus, “availability” of the oxygenated blood
[26-28]. Smith et al. [26] have shown in young lambs, by
using labeled albumin microspheres injected into carotid
perfusion cannula, that relative coronary blood flow was
significantly less than in the control group. Kato et al.
[27] demonstrated in puppies, that coronary arterial flow
in VA ECMO with carotid arterial cannula decreased
even proportionally to ECMO flow increase despite no
significant changes in the mean or diastolic pressures in
the ascending aorta. And most interestingly, Kamimura
et al. [28], in neonatal dogs, proved the difference in cor-
onary blood flow distributed from the proximal arterial
cannula (1 cm above aortic valve) being significantly
higher than that from the distal cannula (ostium of the
brachiocephalic trunk). He concludes that proximal
arterial cannula appears necessary to provide sufficient
oxygenated blood to the coronary circulation during V-A
Figure 5 Coronary artery and coronary sinus lactate levels and myocardial oxygen extraction during the protocol. Lactate levels (panel
A) steeply rise during cardiac arrest in both arms. In the FS arm, lactate rise persists even during the first ECMO treatment and reaches
significantly higher plateau levels than in the FF arm both for arterial and CS values (P = 0.016 and P = 0.035, respectively). Significantly higher
levels in the FS arm persist during the rest of the protocol, however in both arms a downward trend can be detected, though more
pronounced in the FF arm. Myocardial oxygen extraction in ml O2/L (panel B) markedly increases during cardiac arrest followed by a steep
decline after starting both ECMO regimens. Values after ECMO start are not significantly different (see text).
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ECMO. However, animals in these three experimental
protocols were not in cardiac arrest. We speculate that
not only distance, but also the angle under which the
outflow arterial cannula in FS approach is located, may
play the role, causing prograde flow in aortic arch, thus
underperfusing coronary arteries. These considerations
are of critical importance in cardiogenic shock with per-
sistent lung failure treated by peripheral ECMO to avoid
coronary perfusion by poorly oxygenated blood ejected
from the left ventricle.
It has also been demonstrated that added pulsatility to
continuous flow mechanical support improves organ per-
fusion in terms of blood flow, flow velocity in coronary
artery [29,30], energy equivalent pressure and surplus
hemodynamic energy, though not having influenced
mean carotid pressure [31,32], and even improves a renal
perfusion [33]. However, in most of these experiments, a
central cannulation approach was used for both inflow
and outflow cannulae. This surgical approach is usually
not used in cardiac arrest patients [17,18]. We, therefore,
investigated whether pulsatility represented by IABP
might play a similar beneficial role also in peripheral con-
figuration of FF vs. FS ECMO in the cardiac arrest model.
Our results show that in this situation, IABP may have an
unfavorable effect on macrocirculation in the FF config-
uration. We speculate that an intermittent aortic occlu-
sion by the IABP balloon may diminish blood flow
available for the aortic root (and thus for coronary
arteries), more than for the aortic arch (and thus for the
carotids). These results are in accordance with a report
by Sauren [34], where addition of IABP in severely hypo-
tensive ECMO-treated animals was not beneficial; how-
ever, the animals were not in cardiac arrest. On the other
hand, the subclavian approach seems to be suitable for
IABP assistance because the outflow cannula is located
proximal to the IABP balloon. Drakos et al. [35] showed
a similarly beneficial effect of IABP pulsatility on coron-
ary artery flow in a proximally implanted nonpulsatile
centrifugal pump in an open chest pig model of profound
cardiogenic shock. Accordingly, the direction of outflow
arterial flow and distance from coronaries is also of
importance [28]. Our results add to the controversy
about the effect of IABP-generated pulsatility both on
macro- and microcirculation; in small non-randomized
clinical studies, Jung [36,37] and den Uil [38] have
reported on a favorable effect of IABP on microcircula-
tion in cardiogenic shock, but Mustermann [39] showed
paradoxically improved microvascular flow after with-
drawing the IABP. Microcirculation changes definitely
play a key role in critical states [40-42] and the role of
pulsatility and different support combinations (that is,
central vs. peripheral, subclavian vs. femoral) on micro-
circulatory changes remains to be further studied.
An important observation of our study is that VA
ECMO significantly increases coronary perfusion pres-
sure over time, mainly in the FF configuration. CoPP
actually reached the baseline values by the end of our
protocol, that is, approximately two hours after the
ECMO onset (Figures 3 and 4, Additional file 4 and
Table 3). When pooling data from all animals, the CoPP
increased progressively from 15.0 mmHg at the end of
the cardiac arrest to 34.0 mmHg five minutes after start-
ing ECMO, rose to 53.0 mmHg at the ECMO switch and
continued to rise to 68.0 mmHg before CPR, not differ-
ent from baseline. The increases in CoPP were more pro-
nounced during the FF ECMO period of the protocol,
which was responsible more than FS ECMO for an over-
all CoPP increase. In contrast to FF ECMO, where base-
line to before CPR values reached the same values, in the
FS ECMO starting cohort, the CoPP at the end of the
protocol still remained significantly lower compared to
baseline (45.5 vs. 78.5 mmHg, respectively, P = 0.041). To
our knowledge, this phenomenon of the CoPP increase
over time during VA ECMO treated cardiac arrest has
not been described before. This finding is important,
because CoPP is a key prerequisite for ROSC in pro-
longed cardiac arrest [43,44]. We can only speculate
about the pathophysiological mechanism behind the low
CoPP during ECMO start and gradual CoPP increase
with time on ECMO; however, vasoplegia with low per-
ipheral resistance post low flow cardiac arrest followed
by improved vasoreactivity during further ECMO reper-
fusion offers a reasonable explanation. We intentionally
did not use vasopressors in this phase of the experiment
in order to observe the „natural” course of ECMO reper-
fusion. In human care, we are used to keeping the perfu-
sion pressure (that is, MAP) within optimal range with
norepinephrine to assure adequately both cerebral flow
and perfusion pressure.
The adequacy of CoPP was reflected by a high resuscit-
ability of our animals (see Additional file 5), despite a
rather strenuous and prolonged protocol. Of note, we
used a demanding definition for ROSC, as stated earlier.
This definition is more strict and difficult to accomplish in
comparison with other ROSC definitions used in similar
settings, that is, “stable pulse with a systolic arterial pres-
sure > 60 mmHg” [45] or “systolic pressure ≥ 80 mmHg
for at least one minute continuously at any time during
the resuscitation effort” [44]. Thus, we consider the VA
ECMO-mediated CoPP increase to be responsible for an
excellent resuscitability and a considerable hemodynamic
stability after early ROSC. These findings are in accor-
dance with myocardial metabolism and recovery as out-
lined in Figure 5. After a steep increase during cardiac
arrest and the initial phase of ECMO treatments, lactate
levels corresponding to global post arrest ischemia reach a
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peak value followed by a plateau level and then a gradual
decline. Interestingly, the peak and plateau lactate levels
are significantly lower in the FF ECMO arm, possibly
reflecting better organ perfusion. Lactate data are in accor-
dance with myocardial O2 extraction: a steep increase dur-
ing untreated cardiac arrest reflecting insufficient coronary
perfusion is immediatelly reversed after initiating ECMO.
Interestingly, no significant difference was noted in O2
extraction related to ECMO treatment arms. The possible
explanation might be that despite detected lower coronary
blood flow and perfusion pressure in the FS ECMO arm,
low O2 extraction, most probably, reflects a sustained
satisfactory O2 supply. This assumption might be sup-
ported by the threshold character of both myocardial O2
balance and CoPP, meaning that critically low levels have
not been reached. However, this observation has to be
interpreted with caution, because the difference in O2
extraction has been detected to be significant between
treatment arms already during the cardiac arrest period
despite similar baseline values. In the FS ECMO arm, still
sufficient CoPP has been generated during the whole pro-
tocol, see Table 3. Such a value is well above the CoPP
considered to be accompanied by a high probability of
ROSC [43,44].
We also designed this experimental study with the
intention to evaluate cerebral and coronary reperfusion
in terms of appropriate reoxygenation. As shown in
Additional file 3 and Table 2, both FF and FS ECMO
regimens offered adequate (that is, not unintentionally
high) brain and peripheral oxygenations expressed by
regional O2 saturations immediatelly after ECMO initia-
tion. Re-oxygenation on ECMO can be easily controlled
when using on-line monitoring of blood gases as in our
protocol, thus avoiding the possible adverse effects of
arterial hyperoxemia on outcome after reperfusion/
ROSC [46,47].
Study limitations
ECMO and IABP have been implanted prior to induction
of cardiac arrest, which is not the „real” clinical scenario
model. However, urgent ECMO implantation (especially
the subclavian approach) during cardiac arrest is a com-
plex invasive procedure that would probably interfere with
the primary aim of this study, that is, proper and accurate
determination of coronary and carotid blood flow veloci-
ties following the cardiac arrest period. Blood flow mea-
surements were not obtained directly using a flow probe,
which, however, would need an open chest model. Instead,
we assumed that Doppler wire acquired APV offers a good
linear relation to blood flow in proximal LCx segments
[19] and thus can be used as a surrogate marker of blood
flow, mainly for detection of flow velocity changes assum-
ing nonsignificant changes in a vessel diameter [20]. We
controlled for potential confounding factors influencing
vessel diameter like pCO2, intravascular volume, level of
vasocontriction and ECMO flow. Obtained APV values
are also potentially influenced by proper wire positioning.
To overcome this limitation, we insisted on a very careful
wire handling to minimize position changes during the
course of the study protocol.
In our cardiac arrest period, the “no-flow” phase was
substituted entirely by a “low-flow” phase due to ECMO
basal flow. However, basal flow was very low (targeted to
5 to 7, never over 10 mL/kg/minute) and monitored
parameters (regional cerebral saturation, lactate, O2
extraction) demonstrated profound changes correspond-
ing to severe organ hypoperfusion. From the technical
reasons, we also had to omit the mechanical chest com-
pressions during the initial „low-flow” cardiac arrest,
because Doppler wire technology is extremely sensitive
to movements and any even very delicate changes in
position, that is, mechanical compressions, would result
in losing the proper position to catch and exactly record
the post arrest flows.
For brain oxygenation, we used NIRS technology to
monitor regional cerebral saturation with its inherent
limitations; that is, not a global cerebral oxygenation
assessment, not a deep tissue penetration, only relative
values in one subject and their change in time can be
used for evaluation. However, this is a very easy, noninva-
sive tool for detection of even minor changes in regional
brain saturation and its use has been validated both in a
pig CPR model [48] and for prognostic assessment in
OHCA survivors on admission to hospital [49].
Different arterial cannula size used for FS (15 F) and FF
(17 F) approach because of the vessel size is another lim-
itation; however, target ECMO flow of 100 mL/kg/min-
ute was achieved and did not differ in both approaches.
And finally, our biomodel was represented by a breed
that has been validated for simulation of human cardiac
arrest and resuscitation [48,50]. Nonetheless, pig anat-
omy differs from human and the presence of bicarotid
trunk instead of two separate carotid arteries and the
angle under which subclavian artery leaves the aorta
might possibly influence our results.
Conclusion
In a simulated model of VA ECMO-treated prolonged
cardiac arrest, our experimental study showed several
important findings. First, the study confirmed that the
increasingly used first line approach for urgent organ
support in refractory arrest (that is, FF ECMO) suffi-
ciently assures both brain and myocardial perfusion, oxy-
genation and rapidly improves the post-arrest metabolic
state. Second, the FS approach, while sufficiently main-
taining brain perfusion, may not be an optimal option to
maintain coronary perfusion and offers worse myocardial
metabolic recovery. Third, and most importantly, the
Bělohlávek et al. Critical Care 2012, 16:R50
http://ccforum.com/content/16/2/R50
Page 10 of 13
addition of IABP to an established VA ECMO is a con-
troversial intervention: in the FF ECMO approach, it sig-
nificantly impairs coronary perfusion and in the FS
approach, coronary perfusion remains the same, still not
reaching 80% of the pre-arrest value. Fourth, VA ECMO
significantly increases coronary perfusion pressure with
time. Of interest, in animals starting with FF approach
pre-arrest values of coronary perfusion pressure have
been reached at the end of our protocol. However, a
trend towards increasing coronary perfusion pressure
with time is apparent also in FS ECMO. The VA ECMO-
mediated CoPP increase is probably responsible for
excellent resuscitability and considerable hemodynamic
stability after early ROSC. Thus, generally, the VA
ECMO-based approach to refractory cardiac arrest pro-
vides a time span for interventions to correct the cause of
the arrest and assures both sufficient vital organ perfu-
sion and sustained resuscitability.
Key messages
• In a pig model of prolonged cardiac arrest, a
femoro-femoral venoarterial ECMO-based approach
provides adequate cerebral and myocardial perfusion
and oxygenation.
• The combination of IABP with FF ECMO may
impair coronary perfusion.
• Both FF and FS ECMO assure adequate coronary
perfusion pressure and sustained resuscitability.
Moreover, FF ECMO provides CoPP rise with time
and provides rapid myocardial metabolic recovery.
Additional material
Additional file 1: Methods.
Additional file 2: Typical Doppler flow wire positions in carotid
(panel A) and coronary (panel B) arteries. Panel A shows subclavian
15 French ECMO cannula (long black arrow), carotid angiography
performed through carotid guiding catheter (short black arrow)
positioned in the ostium of left carotid artery (long white arrow) and the
tip of the Doppler flow wire (short white arrow), also shown in the box
detail without contrast agent injection. Panel B shows coronary
angiography with left anterior descending (LAD) (small black arrow) and
left circumflex arteries (LCx) (long black arrow) and similarly in detailed
box a tip of the Doppler wire in the proximal straight part of LCx (black
arrowhead). At the bottom shown typical Doppler wire tracings obtained
during cardiac arrest and running VA ECMO from carotid (panel C, APV =
41 cm/sec) and coronary (panel D, APV = 22 cm/sec) arteries. APV =
average peak value.
Additional file 3: Regional oxygen saturations measured by near
infrared spectroscopy shown as percentage of baseline. After a
dramatic decrease during cardiac arrest, sufficient restoration of both
brain and peripheral saturations by all treatments is demonstrated. No
significant difference for any of the comparisons noted. For actual values
see Table 2. FS, femoro-subclavian; FF, femoro-femoral; IABP, intraaortic
balloon counterpulsation.
Additional file 4: Coronary perfusion pressure as measured in
individual animals. The two animals with pressure drop (#1 and #2)
marked by black arrows.
Additional file 5: Resuscitability of animals, number of
defibrillations and ROSC presence (YES/NO) at 5 and 60 minutes. As
vasopressors, epinephrine (Epi) and norepinephrine (Norepi) boluses
followed by continuous IV drip were used only after defibrillations and
CPR, doses given in mg for boluses and μg/kg/min for IV drip
(norepinephrine).
Abbreviations
APV: average peak value; CA: cardiac arrest; CaBF: carotid blood flow; CoBF:
coronary blood flow; CoPP: coronary perfusion pressure; CPR:
cardiopulmonary resuscitation; CVP: central venous pressure; DC: direct
current; ECMO: extracorporeal membrane oxygenation; E-CPR: extracorporeal
cardiopulmonary resuscitation; FF: femoro-femoral; FS: femoro-subclavian;
IABP: intraaortic balloon counterpulsation; IM: intramuscular; IV: intravenous;
LCx: left circumflex artery; MAP: mean arterial pressure; Min: minute; NIRS:
near infrared spectroscopy; OHCA: out of hospital cardiac arrest; PCWP:
pulmonary capillary wedge pressure; PEA: pulseless electrical activity; ROSC:
return of spontaneous circulation; SV: supraventricular; VA: venoarterial; VF:
ventricular fibrillation.
Acknowledgements
We thank Tereza Vavrikova and Alena Ehrichova for their technical
assistance. This study was supported by a research grant from the Ministry
of Education, Youth and Sports, Czech Republic, SVV-2011-254-262504. This
study was supported by a research grant from the Ministry of Education,
Youth and Sports, Czech Republic, MSMT 0021620817.
Author details
12nd Department of Medicine - Department of Cardiovascular Medicine, First
Faculty of Medicine, Charles University in Prague and General University
Hospital in Prague, U Nemocnice 2, Prague 2, 128 00, Czech Republic.
2Department of Physiology, 1st Faculty of Medicine, Charles University in
Prague, Albertov 5, Prague 2, 128 00, Czech Republic. 3BioDat Research
Group, Department of Cybernetics, Faculty of Electrical Engineering, Czech
Technical University in Prague, Karlovo namesti 13, Prague 2, 121 35, Czech
Republic. 4Department of Cardiology, Na Homolce Hospital, Roentgenova 2/
37, Prague 5, 150 30, Czech Republic. 52nd Department of Surgery,
Cardiovascular Surgery, First Faculty of Medicine, Charles University in Prague
and General University Hospital in Prague, U Nemocnice 2, Prague 2, 128 00,
Czech Republic. 6Translational Ultrasound Research Laboratory, Division of
Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Authors’ contributions
JB conceived the study, designed the study protocol, performed the main
procedures during the study, and prepared and finalized the manuscript.
MM, TS, SH and TK assisted during the study performance and drafted the
article. MH and TB performed data acquisition and statistical analysis. MB, AL,
PO and OK participated in a design of the study, contributed to the
interpretation of the results, and helped to draft the manuscript. FM was
responsible for ECMO institution. MA, AL and VM obtained research funding.
All authors read and approved the final manuscript for publication.
Competing interests
All authors have no commercial associations that might impose a conflict of
interest.
Received: 29 December 2011 Revised: 24 February 2012
Accepted: 16 March 2012 Published: 16 March 2012
References
1. Mégarbane B, Leprince P, Deye N, Résière D, Guerrier G, Rettab S,
Théodore J, Karyo S, Gandjbakhch I, Baud FJ: Emergency feasibility in
medical intensive care unit of extracorporeal life support for refractory
cardiac arrest. Intensive Care Med 2007, 33:758-764.
2. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC,
Chi NH, Wang CH, Chen LC, Tsai PR, Wang SS, Hwang JJ, Lin FY:
Cardiopulmonary resuscitation with assisted extracorporeal life-support
versus conventional cardiopulmonary resuscitation in adults with in-
Bělohlávek et al. Critical Care 2012, 16:R50
http://ccforum.com/content/16/2/R50
Page 11 of 13
hospital cardiac arrest: an observational study and propensity analysis.
Lancet 2008, 16:554-561.
3. Adnet F, Baud F, Cariou A, Carli P, Combes A, Devictor D, Dubois-Randé JL,
Gérard JL, Gueugniaud PY, Ricard-Hebon A, Langeron O, Leprince P,
Longrois D, Pavie A, Pouard P, Rozé JC, Trochu JN, Vincentelli A: Guidelines
for indications for the use of extracorporeal life support in refractory
cardiac arrest. French Ministry of Health. Ann Fr Anesth Reanim 2009,
28:182-190.
4. Kagawa E, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Kurisu S, Nakama Y,
Dai K, Takauki O, Ikenaga H, Morimoto Y, Ejiri K, Oda N: Assessment of
outcomes and differences between in- and out-of-hospital cardiac arrest
treated with cardiopulmonary resuscitation with extracorporeal life
support. Resuscitation 2010, 81:968-973.
5. Jasbi BE, Ortiz B, Alla KR, Smith SC, Glaser D, Walsh C, Chillcott S,
Stahovich M, Adamson R, Dembitsky W: A 20-year experience with urgent
percutaneous cardiopulmonary bypass for salvage of potential survivors
of refractory cardiovascular collapse. J Thorac Cardiovasc Surg 2010,
139:753-757.
6. Morimura N, Sakamoto T, Nagao K, Asai Y, Yokota H, Tahara Y, Atsumi T,
Nara S, Hase M: Extracorporeal cardiopulmonary resuscitation for out-of-
hospital cardiac arrest: A review of the Japanese literature. Resuscitation
2011, 82:10-14.
7. Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B,
Langeron O: Extracorporeal life support following out-of-hospital
refractory cardiac arrest. Crit Care 2011, 15:R29.
8. Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G, Buklas D,
Thuaudet S, Charbonneau P, Hamon M, Grollier G, Gerard JL, Khayat A:
Back from irreversibility: extracorporeal life support for prolonged
cardiac arrest. Ann Thorac Surg 2005, 79:178-183, discussion 183-184.
9. Thiagarajan RR, Laussen PC, Rycus PT, Bartlett RH, Bratton SL:
Extracorporeal membrane oxygenation to aid cardiopulmonary
resuscitation in infants and children. Circulation 2007, 116:1693-1700.
10. Kane DA, Thiagarajan RR, Wypij D, Scheurer MA, Fynn-Thompson F,
Emani S, del Nido PJ, Betit P, Laussen PC: Rapid-response extracorporeal
membrane oxygenation to support cardiopulmonary resuscitation in
children with cardiac disease. Circulation 2010, 122:S241-S248.
11. Peek GJ: Community extracorporeal life support for cardiac arrest - when
should it be used? Resuscitation 2011, 82:1117.
12. O’Connor RE, Bossaert L, Arntz HR, Brooks SC, Diercks D, Feitosa-Filho G,
Nolan JP, Vanden Hoek TL, Walters DL, Wong A, Welsford M, Woolfrey K:
Acute Coronary Syndrome Chapter Collaborators. Part 9: Acute coronary
syndromes: 2010 International Consensus on Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care Science With
Treatment Recommendations. Circulation 2010, 122:S422-S465.
13. Mateen FJ, Josephs KA, Trenerry MR, Felmlee-Devine MD, Weaver AL,
Carone M, White RD: Long-term cognitive outcomes following out-of-
hospital cardiac arrest: A population-based study. Neurology 2011,
77:1438-1445.
14. Becker LB, Aufderheide TP, Geocadin RG, Callaway CW, Lazar RM,
Donnino MW, Nadkarni V, Abella BS, Adrie C, Berg RA, Merchant RA,
O’Connor RE, Meltzer DO, Holm MB, Longstreth WT, Halperin HR: Primary
outcomes for resuscitation science studies: a consensus statement from
the American Heart Association. Circulation 2011, 124:2158-2177.
15. Madershahian N, Wippermann J, Liakopoulos O, Wittwer T, Kuhn E, Er F,
Hoppe U, Wahlers T: The acute effect of IABP-induced pulsatility on
coronary vascular resistance and graft flow in critical ill patients during
ECMO. J Cardiovasc Surg (Torino) 2011, 52:411-418.
16. Miyamoto S, Hadama T, Mori Y, Shigemitsu O, Sako H, Uchida U:
Hemodynamic profiles during concurrent intraaortic balloon pumping
and venoarterial bypass-a canine study comparing subclavian and
femoral artery perfusion sites. Jpn Circ J 1995, 59:693-703.
17. Stulak JM, Dearani JA, Burkhart HM, Barnes RD, Scott PD, Schears GJ: ECMO
cannulation controversies and complications. Semin Cardiothorac Vasc
Anesth 2009, 13:176-182.
18. Ganslmeier P, Philipp A, Rupprecht L, Diez C, Arlt M, Mueller T, Pfister K,
Hilker M, Schmid C: Percutaneous cannulation for extracorporeal life
support. Thorac Cardiovasc Surg 2011, 59:103-107.
19. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J:
Validation of a Doppler guide wire for intravascular measurement of
coronary artery flow velocity. Circulation 1992, 85:1899-1911.
20. Olivecrona GK, Götberg M, Harnek J, Van der Pals J, Erlinge D: Mild
hypothermia reduces cardiac post-ischemic reactive hyperemia. BMC
Cardiovasc Disord 2007, 75.
21. Shen I, Levy FH, Benak AM, Rothnie CL, O’Rourke PP, Duncan BW,
Verrier ED: Left ventricular dysfunction during extracorporeal membrane
oxygenation in a hypoxemic swine model. Ann Thorac Surg 2001,
71:868-871.
22. Shen I, Levy FH, Vocelka CR, O’Rourke PP, Duncan BW, Thomas R, Verrier ED:
Effect of extracorporeal membrane oxygenation on left ventricular
function of swine. Ann Thorac Surg 2001, 71:862-867.
23. Pyles LA, Gustafson RA, Fortney J, Einzig S: Extracorporeal membrane
oxygenation induced cardiac dysfunction in newborn lambs. J Cardiovasc
Transl Res 2010, 3:625-634.
24. Seo T, Ito T, Iio K, Kato J, Takagi H: Experimental study on the
hemodynamic effects of veno-arterial extracorporeal membrane
oxygenation with an automatically driven blood pump on puppies. Artif
Organs 1991, 15:402-407.
25. Yu JJ, Son HS, Lim CH, Lee JJ, Park YW, Her K, Won YS, Sun K, Choi JY:
Comparison of myocardial loading between asynchronous pulsatile and
nonpulsatile percutaneous extracorporeal life support. ASAIO J 2008,
54:177-180.
26. Smith HG, Whittlesey GC, Kundu SK, Salley SO, Kuhns LR, Chang CH,
Klein MD: Regional blood flow during extracorporeal membrane
oxygenation in lambs. ASAIO Trans 1989, 35:657-660.
27. Kato J, Seo T, Ando H, Takagi H, Ito T: Coronary arterial perfusion during
venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc
Surg 1996, 111:630-636.
28. Kamimura T, Sakamoto H, Misumi K: Regional blood flow distribution from
the proximal arterial cannula during veno-arterial extracorporeal
membrane oxygenation in neonatal dog. J Vet Med Sci 1999, 61:311-315.
29. Son HS, Sun K, Fang YH, Park SY, Hwang CM, Park SM, Lee SH, Kim KT,
Lee IS: The effects of pulsatile versus non-pulsatile extracorporeal
circulation on the pattern of coronary artery blood flow during cardiac
arrest. Int J Artif Organs 2005, 28:609-616.
30. Jung JS, Son HS, Lim CH, Sun K: Pulsatile versus nonpulsatile flow to
maintain the equivalent coronary blood flow in the fibrillating heart.
ASAIO J 2007, 53:785-790.
31. Lim CH, Son HS, Baek KJ, Lee JJ, Ahn CB, Moon KC, Khi W, Lee H, Sun K:
Comparison of coronary artery blood flow and hemodynamic energy in
a pulsatile pump versus a combined nonpulsatile pump and an intra-
aortic balloon pump. ASAIO J 2006, 52:595-597.
32. Lim CH, Son HS, Fang YH, Lee JJ, Baik KJ, Kim KH, Kim BS, Lee HW, Sun K:
Hemodynamic energy generated by a combined centrifugal pump with
an intra-aortic balloon pump. ASAIO J 2006, 52:592-594.
33. Kim HK, Son HS, Fang YH, Park SY, Hwang CM, Sun K: The effects of
pulsatile flow upon renal tissue perfusion during cardiopulmonary
bypass: a comparative study of pulsatile and nonpulsatile flow. ASAIO J
2005, 51:30-36.
34. Sauren LD, Reesink KD, Selder JL, Beghi C, van der Veen FH, Maessen JG:
The acute effect of intra-aortic balloon counterpulsation during
extracorporeal life support: an experimental study. Artif Organs 2007,
31:31-38.
35. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P,
Pierrakos C, Charitos E, Karelas J, Nanas JN: Comparison of pulsatile with
nonpulsatile mechanical support in a porcine model of profound
cardiogenic shock. ASAIO J 2005, 51:26-29.
36. Jung C, Lauten A, Roediger C, Fritzenwanger M, Schumm J, Figulla HR,
Ferrari M: In vivo evaluation of tissue microflow under combined therapy
with extracorporeal life support and intra-aortic balloon
counterpulsation. Anaesth Intensive Care 2009, 37:833-835.
37. Jung C, Rödiger C, Fritzenwanger M, Schumm J, Lauten A, Figulla HR,
Ferrari M: Acute microflow changes after stop and restart of intra-aortic
balloon pump in cardiogenic shock. Clin Res Cardiol 2009, 98:469-475.
38. den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Brugts JJ, Spronk PE,
Simoons ML: The effects of intra-aortic balloon pump support on
macrocirculation and tissue microcirculation in patients with cardiogenic
shock. Cardiology 2009, 114:42-46.
39. Munsterman LD, Elbers PW, Ozdemir A, van Dongen EP, van Iterson M,
Ince C: Withdrawing intra-aortic balloon pump support paradoxically
improves microvascular flow. Critical Care 2010, 14:R161.
Bělohlávek et al. Critical Care 2012, 16:R50
http://ccforum.com/content/16/2/R50
Page 12 of 13
40. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL: Microvascular
alterations in patients with acute severe heart failure and cardiogenic
shock. Am Heart J 2004, 147:91-99.
41. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent
microcirculatory alterations are associated with organ failure and death
in patients with septic shock. Crit Care Med 2004, 32:1825-1831.
42. Top AP, Ince C, van Dijk M, Tibboel D: Changes in buccal microcirculation
following extracorporeal membrane oxygenation in term neonates with
severe respiratory failure. Crit Care Med 2009, 37:1121-1124.
43. Paradis NA, Martin GB, Rivers EP, Goetting MG, Appleton TJ, Feingold M,
Nowak RM: Coronary perfusion pressure and the return of spontaneous
circulation in human cardiopulmonary resuscitation. JAMA 1990,
263:1106-1113.
44. Reynolds JC, Salcido DD, Menegazzi JJ: Coronary perfusion pressure and
return of spontaneous circulation after prolonged cardiac arrest. Prehosp
Emerg Care 2010, 14:78-84.
45. Halperin HR, Lee K, Zviman M, Illindala U, Lardo A, Kolandaivelu A,
Paradis NA: Outcomes from low versus high-flow cardiopulmonary
resuscitation in a swine model of cardiac arrest. Am J Emerg Med 2010,
28:195-202.
46. Neumar RW: Optimal oxygenation during and after cardiopulmonary
resuscitation. Curr Opin Crit Care 2011, 17:236-240.
47. Kilgannon JH, Jones AE, Parrillo JE, Dellinger RP, Milcarek B, Hunter K,
Shapiro NI, Trzeciak S: Emergency Medicine Shock Research Network
(EMShockNet) Investigators. Relationship between supranormal oxygen
tension and outcome after resuscitation from cardiac arrest. Circulation
2011, 123:2717-2722.
48. Xanthos T, Bassiakou E, Koudouna E, Tsirikos-Karapanos N, Lelovas P,
Papadimitriou D, Dontas I, Papadimitriou L: Baseline hemodynamics in
anesthetized landrace-large white swine: reference values for research in
cardiac arrest and cardiopulmonary resuscitation models. J Am Assoc Lab
Anim Sci 2007, 46:21-25.
49. Ito N, Nanto S, Nagao K, Hatanaka T, Nishiyama K, Kai T: Regional cerebral
oxygen saturation on hospital arrival is a potential novel predictor of
neurological outcomes at hospital discharge in patients with out-of-
hospital cardiac arrest. Resuscitation 2012, 83:46-50.
50. Xanthos T, Lelovas P, Vlachos I, Tsirikos-Karapanos N, Kouskouni E, Perrea D,
Dontas I: Cardiopulmonary arrest and resuscitation in Landrace/Large
White swine: a research model. Lab Anim 2007, 41:353-362.
doi:10.1186/cc11254
Cite this article as: Bělohlávek et al.: Coronary versus carotid blood flow
and coronary perfusion pressure in a pig model of prolonged cardiac
arrest treated by different modes of venoarterial ECMO and intraaortic
balloon counterpulsation. Critical Care 2012 16:R50.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bělohlávek et al. Critical Care 2012, 16:R50
http://ccforum.com/content/16/2/R50
Page 13 of 13
